Pablo David Grigol Martinez

Pablo David Grigol Martinez

Auto-generated profile, based on publicly available information

Pablo David Grigol Martinez

Affiliation Institute of Chemistry, University of Campinas (UNICAMP), Campinas-SP, Brazil

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

22 February 2021 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
RFRafael Augusto Alves Ferreira
Rafael Augusto Alves Ferreira
celso de oliveira Rezende Júniorcelso de oliveira Rezende Júnior
celso de oliveira Rezende Júnior
PMPablo David Grigol Martinez
Pablo David Grigol Martinez
PKPaul John Koovits
Paul John Koovits
BSBruna Miranda Soares
Bruna Miranda Soares
LDLuiz Carlos Dias
Luiz Carlos Dias
Leishmaniasis is a major infectious disease with hundreds of thousands of new cases and over 20,000 deaths each year. The current drugs to treat this life-threatening infection have several drawbacks such as toxicity and long treatment regimens. A library of 1.8 million compounds, from which the hits reported here are publicly available, was screened against Leishmania infantum as part of an optimization program; a compound was found with a 2-aminobenzimidazole functionality presenting moderate potency, low metabolic stability and high lipophilicity. Several rounds of synthesis were performed to incorporate chemical groups capable of reducing lipophilicity and clearance, leading to the identification of compounds that are active against different parasite strains and have improved in vitro properties. As a result of this optimization program, a group of compounds was further tested in anticipation of in vivo evaluation. In vivo tests were carried out with compounds 29 (L. infantum IC50: 4.1 μM) and 39 (L. infantum IC50: 0.5 μM) in an acute L. infantum VL mouse model, which showed problems of poor exposure and lack of efficacy, despite the good in vitro potency.

3 April 2017 in European Journal of Organic Chemistry
Verified
Journal Article
Closed access
PDF file
MGMarla N. Godoi
Marla N. Godoi
Francisco de AzambujaFrancisco de Azambuja
Francisco de Azambuja
PMPablo David G. Martinez
Pablo David G. Martinez
NMNelson H. Morgon
Nelson H. Morgon
VSVanessa G. Santos
Vanessa G. Santos
CCCarlos Roque D. Correia
Carlos Roque D. Correia

17 April 2008 in ChemInform
Verified
Journal Article
Closed access
PDF file
ZLZhijian Liu
Zhijian Liu
FSFeng Shi
Feng Shi
PMPablo D. G. Martinez
Pablo D. G. Martinez
CRCristiano Raminelli
Cristiano Raminelli
RLRichard C. Larock
Richard C. Larock

1 December 2013
Verified
Conference Paper
Closed access
PDF file
PMPablo David G. Martinez
Pablo David G. Martinez
CCCarlos Roque D. Correia
Carlos Roque D. Correia
Bulgecins are bacterial metabolites that interfere with the cell-wall synthesis of Gramnegative bacteria when used in combination with - lactams antibiotics....